Classify hypersensitivity reactions. Describe the mechanism of each type with examples.
Definition
Hypersensitivity is an excessive or inappropriate immune response to an antigen, which injures the host’s own tissues.
- The immune mechanism is normal; it is the response that is excessive or misdirected
- Requires prior sensitisation — the first exposure causes no reaction
- Classified by Gell and Coombs into four types
The Four Types at a Glance
| Type | Name | Mediated by | Time of onset | Prototype |
|---|---|---|---|---|
| I | Immediate (anaphylactic) | IgE on mast cells | Minutes | Anaphylaxis, asthma, hay fever, urticaria |
| II | Antibody-mediated (cytotoxic) | IgG or IgM against cell-surface or matrix antigen | Minutes to hours | Autoimmune haemolytic anaemia, Goodpasture, Graves, myasthenia |
| III | Immune complex | Antigen–antibody complexes with complement | Hours (4–10) | SLE, post-streptococcal glomerulonephritis, serum sickness |
| IV | Cell-mediated (delayed) | T lymphocytes — no antibody at all | 24–72 hours | Tuberculin test, contact dermatitis, granulomas, transplant rejection |
- Mnemonic — acid: Anaphylactic, Cytotoxic, Immune complex, Delayed
- Types I to III are antibody-mediated; type IV is cell-mediated — the single most useful division
Type I — Immediate Hypersensitivity
First exposure — antigen presented, TH2 response, IL-4 and IL-13 drive B cells to make IgE → IgE binds FcεRI receptors on mast cells and basophils — the person is now sensitised → Re-exposure — antigen cross-links two adjacent IgE molecules → Mast cell degranulation → immediate phase (5–30 minutes) — preformed histamine: vasodilatation, increased permeability, bronchospasm, mucus → late phase (2–24 hours) — newly synthesised leukotrienes, prostaglandins, cytokines; eosinophil infiltration and tissue damage
- The late phase causes the tissue damage, and is why asthma is treated with steroids rather than antihistamines alone
- Atopy — a genetic predisposition to exaggerated IgE responses; familial, with raised serum IgE and eosinophils
Type II — Antibody-mediated
| Mechanism | Explanation | Examples |
|---|---|---|
| Complement-mediated lysis | Antibody fixes complement; the membrane attack complex lyses the cell | Mismatched transfusion, autoimmune haemolytic anaemia, haemolytic disease of the newborn |
| Opsonisation and phagocytosis | C3b and Fc receptors on phagocytes | Immune thrombocytopenic purpura |
| Antibody-dependent cell-mediated cytotoxicity | NK cells and macrophages bind the Fc portion | Parasites; tumour cells; transplant rejection |
| Antibody-mediated inflammation | Complement and Fc receptors recruit neutrophils | Goodpasture syndrome, acute rheumatic fever, pemphigus |
| Cellular dysfunction without damage | Antibody stimulates or blocks a receptor | Stimulating — graves disease (TSH receptor). Blocking — myasthenia gravis (acetylcholine receptor), pernicious anaemia (intrinsic factor) |
CLINICAL PEARL
Graves disease and myasthenia gravis are the same mechanism with opposite results. In both, antibody binds a receptor without destroying the cell. In Graves it mimics the hormone and switches the receptor on; in myasthenia it blocks the receptor and switches it off. This subgroup is worth stating separately, because there is no cell death at all.
Type III — Immune Complex Disease
Antigen–antibody complexes form in the circulation → Complexes of intermediate size in slight antigen excess are the pathogenic ones — too small to be cleared, too large to pass → Deposit where there is filtration or turbulence: glomeruli, joints, skin, small vessels, pericardium → Complement is activated → C3a and C5a → neutrophils are recruited and release lysosomal enzymes and radicals → fibrinoid necrosis and vasculitis
| Form | Features | Examples |
|---|---|---|
| Systemic | Complexes form in the blood and deposit widely | Serum sickness, SLE, post-streptococcal glomerulonephritis, polyarteritis nodosa |
| Local (ARTHUS reaction) | Complexes form in situ where antigen is injected into a sensitised person; local vasculitis and necrosis in 4–10 hours | Hypersensitivity pneumonitis — farmer’s lung |
Type IV — Delayed (cell-mediated)
| Subtype | Mechanism | Examples |
|---|---|---|
| Delayed-type hypersensitivity | CD4 TH1 cells release IFN-gamma, activating macrophages | Tuberculin (Mantoux) reaction, contact dermatitis, granulomatous inflammation of tuberculosis and leprosy |
| T cell-mediated cytotoxicity | CD8 cytotoxic T cells kill the target directly, by perforin and granzyme, or through Fas | Type 1 diabetes, multiple sclerosis, viral hepatitis, graft rejection |
- No antibody is involved, so type IV cannot be transferred by serum — only by lymphocytes. This is the classical experimental proof
- Persistent antigen converts a delayed reaction into a granuloma after two to three weeks
Applied Aspects
- Anaphylaxis is treated with intramuscular adrenaline, which reverses every effect of the mediators; antihistamines and steroids are adjuncts only
- Skin prick testing demonstrates type I; the Mantoux test demonstrates type IV, read at 48–72 hours
- Direct and indirect Coombs tests detect type II antibody on or against red cells
- Rh haemolytic disease is a type II reaction prevented entirely by anti-D immunoglobulin — one of the great successes of applied immunopathology
- Serum sickness is now seen with antivenom and antithymocyte globulin, appearing 7–10 days after the first exposure
- Contact dermatitis to nickel, chromate and rubber is a type IV reaction diagnosed by patch testing
- Desensitisation (allergen immunotherapy) shifts the response from IgE toward blocking IgG and regulatory T cells, and is the only treatment that alters the natural history of allergy
- Asthma is a type I reaction with a dominant late phase, which is why inhaled corticosteroids are the mainstay and bronchodilators alone are inadequate
- Transfusion reactions — acute haemolytic reactions are type II and ABO-related; febrile non-haemolytic reactions are caused by donor leucocytes and are prevented by leucodepletion
- Hyperacute graft rejection is a type II reaction, and acute cellular rejection a type IV one — the same classification applies throughout transplantation
- Tuberculin conversion indicates infection, not disease, and its interpretation must allow for BCG vaccination, which is universal in India
- Corticosteroids suppress all four types, which is why they are so widely used and so readily abused
- Penicillin can cause all four types — anaphylaxis (I), haemolytic anaemia (II), serum sickness (III) and contact dermatitis (IV); a single drug illustrating the entire classification
- Eosinophilia points to type I or to parasitic infestation, and both are common in India
- Total and specific IgE support a diagnosis of atopy, but skin prick testing remains more sensitive and far cheaper
- Latex allergy is an occupational hazard for health workers, and may be type I or type IV; the two require different tests
- Hypersensitivity is the mechanism behind much of clinical medicine — asthma, drug reactions, autoimmune disease, transplant rejection and the tuberculin test all belong to this single classification
- Omalizumab, an anti-IgE antibody, is used in severe allergic asthma and acts precisely at the first step of the type I pathway
- Type II and type III are distinguished by where the antigen is — fixed on a cell surface in type II, and free in the circulation forming complexes in type III. That single question separates them reliably
All questions in Immunopathology
- Q1Classify hypersensitivity reactions. Describe the mechanism of each type with examples. ★
- Q2Describe the aetiopathogenesis, autoantibodies and morphology of systemic lupus erythematosus. ★
- Q3Describe the pathogenesis and natural history of HIV infection. Add a note on the opportunistic infections and tumours of AIDS. ★
- Q4Describe the types and mechanisms of transplant rejection. Add a note on graft-versus-host disease. ★
- Q5Classify immunodeficiency disorders. Describe the important primary immunodeficiencies and the causes of secondary immunodeficiency. ★
- SN1Describe anaphylaxis with its causes, mechanism and management. ★
- SN2Describe the important autoantibodies with their disease associations. ★
- SN3Describe the HLA system with its classes and functions. Add a note on its disease associations. ★
- SN4Describe the pathogenesis and morphology of rheumatoid arthritis. ★
- SN5Describe immunological tolerance and the mechanisms by which it is lost. ★
- SN6Describe systemic sclerosis with its types, pathogenesis and organ involvement.
- SN7Describe graft-versus-host disease with its requirements, features and prevention.